" /> CDK Inhibitor AT7519 - CISMeF





Preferred Label : CDK Inhibitor AT7519;

NCIt synonyms : Cyclin-Dependent Kinase Inhibitor AT7519M;

NCIt related terms : CDKI AT7519; AT7519M; CDK inhibitor AT7519M; AT-7519;

NCIt definition : An orally bioavailable small molecule with potential antineoplastic activity. AT7519M selectively binds to and inhibits cyclin dependent kinases (CDKs), which may result in cell cycle arrest, induction of apoptosis, and inhibition of tumor cell proliferation. CDKs are serine/threonine kinases involved in regulation of the cell cycle and may be overexpressed in some types of cancer cells.;

Alternative definition : NCI-GLOSS: A substance being studied in the treatment of some types of cancer. AT7519M blocks enzymes needed for cells to divide. It is a type of cyclin-dependent kinase inhibitor.;

UNII : X1BF92PW9T;

CAS number : 844442-38-2; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 844442-38-2 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : AT7519; AT7519M;

Chemical formula : C16H17Cl2N5O2;

Codes from synonyms : CDR0000530319; CDR0000546733;

Details


You can consult :


Nous contacter.
14/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.